ReviewAdvances in biochemical engineering/biotechnology2026
Mathematical Modeling.
Review in Advances in biochemical engineering/biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solution crystallization is becoming increasingly important as separation, purification, and controlled particle formation of biomolecules in pharmaceutical applications, with high potential as a green and scalable method at an industrial level. As this book's previous chapters discussed already, a large amount of attention is paid to the fundamental aspects of nucleation and growth, as triggering the crystallization of macromolecules is often challenging. Once the suitable ranges of the key thermodynamic conditions are identified, such as the solvent system, precipitating agent, concentration, pH, and temperature, the toolsets of the crystallization process engineering, relying on mathematical modeling, can support the process understanding, design, optimization, and control/operation.As a primer to this chapter, one must keep in mind that the results drawn from the relatively small number of proteins and other biomolecular systems studied in detail in the past indicate that a strong correspondence exists between the growth behavior and mechanisms of the biomolecule crystals with theories accumulated into the crystallization of inorganic small-molecule crystals. Although there is no guarantee that all protein and other biomolecular systems analyzed in the future will obey the same or similar fundamental rules, given the available evidence, a generic crystallization modeling and control overview will be given here. This chapter is divided into two main sections. Firstly, the mathematical modeling and simulation aspects will be described, which can help to understand, analyze, and optimize the processes on a manufacturing level. Secondly, control solutions will be presented for crystallizers that enable the realization of the desired products.
Indexed as
Identifiers
41820682What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.